joints, and that clinical improvement after corticosteroid therapy is reflected by a reduction in maximum or 'peak' uptake of radionuclide by the joint (Dick, Neufelt, and others, 1970) .
In this preliminary investigation we have studied the peak uptake of '9mTc, monitored by external directional counting, in conjunction with a selection of standard methods of assessment. Any new method of assessment must be shown to work in a relevant clinical situation. We have employed a clinical trial of two widely-used anti-inflammatory agentssodium salicylate and indomethacin-as a means of assessing the measurement of peak uptake of 99mTc over the knee joint as an index of inflammatory activity. The sensitivity of this measure was compared with other standard clinical tests and with the rate of disappearance of another radionuclide xenon (133Xe) from the knee joint (Dick, Dick, Nuki, Whaley, Boyle, Shenkin, Downie, and Buchanan 1969; Dick, Whaley, St. Onge, Downie, Boyle, Nuki, Gillespie, and Buchanan 1970; St. Onge, Gillespie, Downie, Nuki, Gordon, ).
Material and methods
Ten patients with 'classical' rheumatoid arthritis (Ropes, Bennett, Cobb, Jacox, and Jessar, 1959) took part in a triple cross-over clinical trial over a period of 3 weeks. Four of these patients were men and the six women patients were post-menopausal. The age range was 39 to 58 years. Each patient volunteered to participate in the trial after explanation of its content and implications.
All patients received three successive treatments of a week each on sodium salicylate (Entrosalyl) 5 g./day, indomethacin (Indocid) 100 mg./day, and lactose as placebo, all given as four divided doses in non-identical capsules. The order of treatments administered is summarized in Table I . At the conclusion of each week's treatment the patients were all assessed by the same observer. Each patient was asked general and then specific questions designed to elicit both the efficacy and sideeffects of the previous week's treatment. An articular Table I Number ofpatients receiving each treatment  in each of three periods   Treatment Indomethacin Sodium Placebo  salicylate  Week 1  2  4  4  2  4  3  3  3  4  3  3 index (Ritchie and others, 1968) was performed, and measurements were made of grip strength (Wright, 1959) and of the circumference of the finger joints using a millimetre gauge (Boardman and Hart, 1967) . One knee joint, selected for a study at the first assessment on the basis of severity of involvement, was then examined. A history of pain and of stiffness was elicited. The degree of tenderness, measured as the response to firm pressure over the joint margin, was tested and the degree of joint swelling was also subjectively assessed. Grading for each of these four criteria was on a fourpoint scale where 0 = absent, 1 = mild, 2-moderate, and 3 severe.
A narrow-bore needle was inserted into the joint cavity and as much synovial fluid as possible was withdrawn. Approximately 50 jkCi of 133Xe in 0 5 ml. sterile sodium chloride were injected into the joint cavity and the needle was withdrawn. The Patients were asked at the end of the 3 weeks of the trial to give a single preference for one of the three treatments.
Results
The individual values obtained on each treatment are shown in Table II 99mTc peak (counts/min.) The results were further analysed statistically. Each of the six methods of assessment was considered separately, using analysis of variance techniques to decide whether there were significant differences in value of any of the methods when the patients were given the three treatments. As shown in Table  I , the triple cross-over design in ten patients did not produce a balanced design. This was due in part to the rejection of results of 99mTc studies, and two patients started on indomethacin whilst four each started on salicylate and placebo. The statistical method used took account of this imbalance in the design. Dummy variables (Quenouille, 1953) were used to test salicylate against indorrethacin (d1) and placebo against active drugs (d2).
These two comparisons were chosen to be orthogonal and form together the total variance between treatments. ing to articular index, knee score, and technetium peak count, but no significant difference was shown using joint size, grip strength, or xenon clearance times.
Discussion
It is notoriously difficult to detect small changes in inflammatory activity reliably and reproducibly (Beecher, 1959) . Many methods of assessment have been investigated, including both clinical and laboratory measurements. The availability of gamma-emitting radionuclides has extended the techniques available for the study of joint inflammation in vivo. The rate of clearance of a freely diffusible lipid soluble radionuclide of small molecular weight injected into the joint provides a measure of tissue perfusion (Dick, St. Onge, and others, 1970) and is thus a measure of only one aspect of the total inflammatory response. On the other hand, the local accumulation of intravenously administered radioactive technetium (99mTc) has been shown to reflect tissue volume, vascularity, and, to some extent, synovial fluid volume. (Whaley and others, 1968; Green and Hays, 1969) . Thus, although less precise, this technique holds more promise as an index of the overall inflammatory process.
In the present clinical trial we have studied the results obtained by two new methods of assessment, in conjunction with previously established methods. The results clearly show that the 133Xe clearance method offers at best only poor discrimination when compared with standard clinical methods, as has been noted previously (Dick and others, 1969) . Thus, although a difference at the 5 per cent. level of significance was demonstrable between placebo and active drug therapy by this technique, the standard methods (articular index, knee score, and grip strength) distinguished the effects of treatment at the 1 per cent. level or better. Since the xenon clearance time reflects tissue perfusion alone (Dick, St. Onge, and others, 1970) , which is only one feature of the total inflammatory response, this result is not altogether surprising.
The change in joint circumference provided even poorcr discrimination than did the results of the xenon studies. Although joint size has been shown to c1hange with adequate anti-inflammatory therapy by some workers (Boardman and Hart, 1967) , alteration attributable to drug effect has been less obvious in other clinical trials (Pitkeathly, Banerjee, R-irris, and Sharp, 1966) . There are many possible explanations for this discrepancy. Most of the joint swelling in the patients in this study represented irreversible change and probably could not be modified by short term anti-inflammatory therapy. On the other hand, the simple determination of peak count rate after an intravenous injection of a measured dose of radioactive technetium seems to offer an index which more closely mirrors clinical change. Thus, the same order of levels of significance achieved when active therapy was compared with placebo by means of the articular index (p < O * 001), kneescore(p < 0 005), andgrip strength (p < 0-01) was also seen with the technetium peak count rate (p < 0 -005). Furthermore, the technetium peak count rate gave the same treatment preference as did the articular index for all ten patients, and both these measures corresponded to the majority trend in the eight patients showing consistent results (Table III) , whilst the xenon clearance test fell short of this.
In eight of the ten patients the result by the radiotechnetium peak count rate agreed with the patients' own treatment preference. Criticism may be levelled at the use of patient preference in a trial which is not blind, but the high level of agreement of the patient's choice with both subjective and objective measurements in this study (Table III) provides some support for its inclusion.
The mean scores (Table VI) for technetium peak count, articular index, knee score, and grip strength all showed better values on indomethacin than on salicylate, and although none of the parameters showed a statistically significant difference the nearest approach to this was the technetium peak count (p-01). Although most authorities consider indomethacin and aspirin in these doses to be roughly equipotent (Sunshine, Laska, Meisner, and Morgan, 1964; Pitkeathly and others, 1966; Pinals and Frank, 1967) , there is some evidence to suggest that indomethacin exerts a more powerful anti-inflammatory effect than aspirin (Ga'spairdy, Ga'spardy, Bailint, and Kemeny, 1966) . The trend of the findings in the present study agree with this.
The results of this small but objective study therefore show that the measurement of peak count rate of radioactive technetium is capable of demonstrating anti-inflammatory effect in a short-term clinical trial of non-steroidal anti-inflammatory drugs. The direction and the degree of change of this measurement compare favourably with results obtained by other clinical methods.
Summary
Ten patients with classical rheumatoid arthritis entered a triple cross-over clinical trial of antiinflammatory treatment using sodium salicylate 5 g./day, indomethacin 100 mg./day, and placebo, each treatment being administered for one week. Six methods of assessment were used, including an articular index, joint size, grip strength, a knee xenon were determined each week. The articular score, and two new methods of assessment derived index, grip strength, knee score, and radiotechnetium from isotope studies. Peak uptake by the knee after peak count rate discriminated change in the inflamthe intravenous administration of radioactive tech-matory process as a result of treatment better than netium and the half-life of intra-articularly injected did joint size or xenon clearance measurements.
